The stock of Biosig Technologies Inc (BSGM) has gone up by 24.72% for the week, with a -11.87% drop in the past month and a -86.46% drop in the past quarter. The volatility ratio for the week is 23.02%, and the volatility levels for the past 30 days are 17.62% for BSGM. The simple moving average for the past 20 days is 13.46% for BSGM’s stock, with a -86.69% simple moving average for the past 200 days.
Is It Worth Investing in Biosig Technologies Inc (NASDAQ: BSGM) Right Now?
Company’s 36-month beta value is 1.22.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BSGM is 7.74M, and currently, short sellers hold a 8.65% ratio of that floaft. The average trading volume of BSGM on April 01, 2024 was 341.78K shares.
BSGM) stock’s latest price update
The stock of Biosig Technologies Inc (NASDAQ: BSGM) has decreased by -9.45 when compared to last closing price of 0.73.Despite this, the company has seen a gain of 24.72% in its stock price over the last five trading days. Zacks Investment Research reported 2023-08-25 that BioSig’s (BSGM) subscription model for PURE EP provides electrophysiologists and cardiology departments with flexibility.
Analysts’ Opinion of BSGM
Many brokerage firms have already submitted their reports for BSGM stocks, with ROTH Capital repeating the rating for BSGM by listing it as a “Buy.” The predicted price for BSGM in the upcoming period, according to ROTH Capital is $9 based on the research report published on March 30, 2020 of the previous year 2020.
BSGM Trading at -36.39% from the 50-Day Moving Average
After a stumble in the market that brought BSGM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.99% of loss for the given period.
Volatility was left at 17.62%, however, over the last 30 days, the volatility rate increased by 23.02%, as shares sank -3.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -77.06% lower at present.
During the last 5 trading sessions, BSGM rose by +24.72%, which changed the moving average for the period of 200-days by -94.58% in comparison to the 20-day moving average, which settled at $0.5813. In addition, Biosig Technologies Inc saw -86.08% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BSGM starting from LONDONER KENNETH L, who purchase 15,600 shares at the price of $1.24 back on Jun 13 ’23. After this action, LONDONER KENNETH L now owns 2,507,020 shares of Biosig Technologies Inc, valued at $19,358 using the latest closing price.
LONDONER KENNETH L, the Chief Executive Officer of Biosig Technologies Inc, purchase 6,000 shares at $1.17 during a trade that took place back on Jun 12 ’23, which means that LONDONER KENNETH L is holding 2,491,420 shares at $7,040 based on the most recent closing price.
Stock Fundamentals for BSGM
Current profitability levels for the company are sitting at:
- -208.11 for the present operating margin
- -2.11 for the gross margin
The net margin for Biosig Technologies Inc stands at -212.76. The total capital return value is set at 38.76. Equity return is now at value -6869.27, with -733.26 for asset returns.
Based on Biosig Technologies Inc (BSGM), the company’s capital structure generated -1.02 points at debt to capital in total, while cash flow to debt ratio is standing at -34.75. The debt to equity ratio resting at -0.5. The interest coverage ratio of the stock is 1333.77.
Currently, EBITDA for the company is -26.97 million with net debt to EBITDA at -0.0. When we switch over and look at the enterprise to sales, we see a ratio of 44.77. The receivables turnover for the company is 10.07for trailing twelve months and the total asset turnover is 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.27.
Conclusion
In a nutshell, Biosig Technologies Inc (BSGM) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
